Burt Wealth Advisors’s Impax Laboratories, Inc. IPXL Stock Holding History

Burt Wealth Advisors’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-506	Closed	-$10K	–	406
2018 Q1	$10K	Hold	506	–	–	0.01%	290
2017 Q4	$8K	Hold	506	–	–	0.01%	288
2017 Q3	$10K	Hold	506	–	–	0.01%	269
2017 Q2	$8K	Hold	506	–	–	0.01%	307
2017 Q1	$6K	Hold	506	–	–	﹤0.01%	295
2016 Q4	$7K	Hold	506	–	–	0.01%	305
2016 Q3	$11K	Hold	506	–	–	0.01%	261
2016 Q2	$14K	Hold	506	–	–	0.02%	247
2016 Q1	$16K	Hold	506	–	–	0.01%	279
2015 Q4	$21K	Hold	506	–	–	0.02%	205
2015 Q3	$17K	Hold	506	–	–	0.02%	202
2015 Q2	$23K	Hold	506	–	–	0.03%	190
2015 Q1	$24K	Hold	506	–	–	0.02%	180
2014 Q4	$16K	Buy	+506	New	+$14.8K	0.02%	203

Burt Wealth Advisors's IPXL Position: Q2 2018 in Review

Burt Wealth Advisors sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 506 shares — an estimated $10K sold.

Burt Wealth Advisors first reported a position in IPXL in Q4 2014 and held it in 14 quarters. The position peaked at $24K in Q1 2015. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

Burt Wealth Advisors reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
Burt Wealth Advisors sold 506 Impax Laboratories, Inc. shares in Q2 2018, an estimated $10K.
Burt Wealth Advisors first reported a position in Impax Laboratories, Inc. in Q4 2014 and held it in 14 quarters.
Burt Wealth Advisors's Impax Laboratories, Inc. position peaked at $24K in Q1 2015.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Burt Wealth Advisors's 13F filing for Q2 2018, filed 27 Jul 2018.